RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

RxSight Inc.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on RxSight (RXST), Kazia Therapeutics (KZIA) and Cres...

Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Kazia Therapeutics (KZIA) and Crescent Biopharma (CBIO)

Wells Fargo analyst maintained a Hold rating on RxSight today and set a price target of $9.00. In addition to Wells Fargo, RxSight also received a ...

Wells Fargo Sticks to Its Hold Rating for RxSight (RXST)

RxSight ( ($RXST) ) has provided an announcement. On June 30, 2026, RxSight entered into a non-exclusive license, collaboration and development agr...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	RXST	$5.40	+2.86%	300.04K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	RXST	$5.40	+2.9%	300.04K
3
4
5
6

RXST

RXST

Get RxSight Inc. Data in Excel

Get RxSight Inc. Data in Excel